Glycemic Management and Lipid Profile in Individuals with Type 2 Diabetes During The COVID-19 Pandemic: An Analytical Cross-Sectional Study
Journal of Microbiota · 2024
DOI: 10.5812/jmb-155607 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift Journal of Microbiota, 2024. Verfasst von Nazanin Daneshpour und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
The global outbreak of COVID-19 has raised concerns about its potential impact on the management of chronic health conditions, particularly diabetes.
Objectives
This cross-sectional study was conducted to assess the effect of COVID-19 on blood sugar control and lipid profiles in individuals with type 2 diabetes.
Methods
This cross-sectional study gathered and analyzed data from 61 diabetic patients between March 2021 and March 2022. Data collected included demographic information, HbA1c levels, and lipid profiles, all obtained from the files at the Endocrine and Metabolism Clinic of Kowsar Hospital.
Results
Among the 61 patients with complete data, 12 (19.7%) tested positive for COVID-19. Statistical analysis revealed no significant differences between the COVID-19 positive and negative groups in terms of age (P = 0.759), HbA1c level (P = 0.209), total cholesterol level (P = 0.841), triglyceride levels (P = 0.876), HDL (P = 0.504), LDL (P = 0.191), or duration of diabetes treatment (P = 0.779). However, significant differences were found between male and female diabetic patients in age (P = 0.030) and total cholesterol levels (P = 0.030), with women being older and having higher total cholesterol. No significant differences were observed between groups treated with oral medication and insulin in terms of age (P = 0.789), HbA1c level (P = 0.584), total cholesterol level (P = 0.263), triglyceride levels (P = 0.162), HDL (P = 0.718), LDL (P = 0.463), or duration of diabetes treatment (P = 0.545).
Conclusions
The findings indicate that COVID-19 did not significantly affect glycemic control or lipid profiles in the studied diabetic population. The observed associations between demographic and clinical factors offer valuable insights into the complex relationship between diabetes and COVID-19.
Zitieren
APA
Daneshpour, N., Motamedi, S. K., Pordanjani, S. R., & Najmaldin, A. (2024). Glycemic Management and Lipid Profile in Individuals with Type 2 Diabetes During The COVID-19 Pandemic: An Analytical Cross-Sectional Study. Journal of Microbiota. https://doi.org/10.5812/jmb-155607
Vancouver
Daneshpour N, Motamedi SK, Pordanjani SR, Najmaldin A. Glycemic Management and Lipid Profile in Individuals with Type 2 Diabetes During The COVID-19 Pandemic: An Analytical Cross-Sectional Study. Journal of Microbiota. 2024. doi:10.5812/jmb-155607
BibTeX
@article{Daneshpour2024,
author = {Daneshpour, Nazanin and Motamedi, Saeb Keshavarz and Pordanjani, Sajjad Rahimi and Najmaldin, Atousa},
title = {Glycemic Management and Lipid Profile in Individuals with Type 2 Diabetes During The COVID-19 Pandemic: An Analytical Cross-Sectional Study},
journal = {Journal of Microbiota},
year = {2024},
doi = {10.5812/jmb-155607}
}
EUVIMED